CVD: Clinical Trials

1 trial for CVD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow CVD: new trials by email Literature Review of CVD trials Research Report on CVD

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction
Dapagliflozin 10mg - PreDiabetes, Myocardial Infarction
Phase 3UnknownHamad Medical Corporation5762019-03-012019-01-03

Narrower conditions

Diabetes Mellitus, Type 2 (1)  ·  Myocardial Infarction (1)  ·  Prediabetic State (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Heart Diseases (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Metabolic Diseases (1)  ·  Myocardial Ischemia (1)  ·  Necrosis (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

dapagliflozin (1)

Sponsors

Hamad Medical Corporation (1)

Countries

Qatar (1)

Top investigators

Jassim Al-Suwaidi, MD (1)

Results publications

PMID 14578255, PMID 16644654, PMID 17315136, PMID 19490820, PMID 23668478, PMID 24631482, PMID 25425451, PMID 25739882, PMID 27679584, PMID 27814267, PMID 28096223, PMID 28428225, PMID 28615237, PMID 29227578